Emerging Trends in the Treatment of Advanced Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common type of skin cancer worldwide [1 –4]. In the United States, BCC is diagnosed in> 2 million patients annually, and global incidence rates continue to rise [1,5,6]. Risk factors for the development of BCC include fair skin type, exposure to ultraviolet radiation, age, history of BCC, genetic disorders (eg, Gorlin syndrome, xeroderma pigmentosum), and immunosuppression [1,2,4,7]. BCC tumors are generally slow growing and rarely metastasize, and the prognosis for patients who receive appropriate therapy is typically very good [1 –3].

Source: Cancer Treatment Reviews - December 14, 2017 Category: Cancer & Oncology Authors: Michael R. Migden, Anne Lynn S. Chang, Luc Dirix, Alexander J. Stratigos, John T. Lear Tags: Anti-Tumour Treatment Source Type: research